US$ 24.37
is tirzepatide a glp-1 agonist Understand GLP-1/GIP Dual and Its Effect on Current Weight Loss Therapy Retatrutide vs Tirzepatide: Which Weight-Loss
Description
Annals of Internal Medicine, 2025

Neurobiol Aging

2,13,15 The occurrence of GI AEs associated with GLP-1 RAs is well established, but direct comparisons of incidence and severity across individual agents are less consistently reported

Future Directions Tirzepatide represents just the beginning of multi-agonist approaches

Whats the difference between GLP-1 and dual agonists